WORLD HEALTH ENERGY HOLDINGS, INC.: 10-Q filed 2012-12-10

Name: WORLD HEALTH ENERGY HOLDINGS, INC.: 10-Q filed 2012-12-10
Creator: WORLD HEALTH ENERGY HOLDINGS, INC.

What WORLD HEALTH ENERGY HOLDINGS, INC. reported in its quarterly report filed 2012-12-10 (fiscal Q2 2012): 21 published measures, 58 facts as tagged in accession 0001493152-12-001898.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-12-10
Fiscal period: fiscal Q2 2012
Accession: 0001493152-12-001898 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All WORLD HEALTH ENERGY HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-06-30	0	USD
At 2011-12-31	212	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-06-30	-309,151	USD
At 2011-12-31	-226,390	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-06-30	0	USD
At 2011-12-31	212	USD
At 2011-06-30	272	USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-212	USD	182
2011-01-01 to 2011-06-30	-35,836	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	36,108	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-06-30	-73,426,977	USD
At 2011-12-31	-73,344,216	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	88,400	USD	182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-29,300	USD	91
2012-01-01 to 2012-06-30	-82,761	USD	182
2011-01-01 to 2011-12-31	-48,428,812	USD	365
2011-04-01 to 2011-06-30	-29,401	USD	91
2011-01-01 to 2011-06-30	-57,628	USD	181
2010-01-01 to 2010-12-31	-115,415	USD	365
2009-01-01 to 2009-12-31	419,570	USD	365
2008-01-01 to 2008-12-31	-16,351	USD	366
2007-01-01 to 2007-12-31	-835,204	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-06-30	0	USD
At 2011-12-31	212	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-06-30	309,151	USD
At 2011-12-31	226,602	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-06-30	58,874	USD
At 2011-12-31	36,888	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	29,300	USD	91
2012-01-01 to 2012-06-30	82,761	USD	182
2011-04-01 to 2011-06-30	29,401	USD	91
2011-01-01 to 2011-06-30	57,628	USD	181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-06-30	0	USD
At 2011-12-31	0	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	0	USD	182
2011-01-01 to 2011-06-30	0	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit
At 2012-06-30	19,789,407,996	shares
At 2011-12-31	4,257,994,016	shares
At 2009-06-30	880,000,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-06-30	28,780,947	USD
At 2011-12-31	28,780,947	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2012-06-30	-30,793,445	USD
At 2011-12-31	-41,579,674	USD
At 2010-12-31	-115,415	USD
At 2009-12-31	452,337	USD
At 2008-12-31	-2,436,791	USD
At 2007-12-31	-2,420,440	USD
At 2006-12-31	-1,772,940	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2012-06-30	4,353	USD
At 2011-12-31	4,353	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-06-30	8,300	USD
At 2011-12-31	8,300	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	17,079	USD	91
2012-01-01 to 2012-06-30	49,687	USD	182
2011-04-01 to 2011-06-30	22,901	USD	91
2011-01-01 to 2011-06-30	39,128	USD	181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	21,986	USD	182
2011-01-01 to 2011-06-30	21,792	USD	181

Inspect the source

Entity: WORLD HEALTH ENERGY HOLDINGS, INC. / CIK 0000943535
Captured: 2026-09-20T05:10:13.576Z
SEC response SHA-256: 92f08c10292ee61a8402393503e39a04177155024d516f8fdc7961e83767f0ba

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000943535.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))